Functional exhaustion of CD4+ T lymphocytes during primary cytomegalovirus infection

Journal of Immunology

Volumn 189, Issue 5, 2012, Pages 2665-2672

  Antoine, Pierre ^a   Olislagers, Véronique ^a   Huygens, Ariane ^a   Lecomte, Sandra ^a   Liesnard, Corinne ^b   Donner, Catherine ^b   Marchant, Arnaud ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; PROGRAMMED DEATH 1 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; CD4+ CD28+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL SPECIFICITY; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; PRIMARY INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHRONIC DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; LYMPHOPENIA; PREGNANCY; VIRUS REPLICATION;

EID: 84865425035     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101165     Document Type: Article

References (50)

1. Gandhi, M. K., and R. Khanna. 2004. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect. Dis. 4: 725-738.
2. Burny, W., C. Liesnard, C. Donner, and A. Marchant. 2004. Epidemiology, pathogenesis and prevention of congenital cytomegalovirus infection. Expert Rev. Anti Infect. Ther. 2: 881-894.
3. Salmon-Céron, D., M. C. Mazeron, S. Chaput, N. Boukli, B. Senechal, N. Houhou, C. Katlama, S. Matheron, A. M. Fillet, J. Gozlan, et al. 2000. Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy. AIDS 14: 1041-1049.
4. Sester, M., U. Sester, B. Gärtner, G. Heine, M. Girndt, N. Mueller-Lantzsch, A. Meyerhans, and H. Köhler. 2001. Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation 71: 1287-1294.
5. + T cells in protection against CMV disease. Blood 101: 2686-2692.
6. + CMV-specific T cells protects against CMV reactivation following allogeneic SCT. Bone Marrow Transplant. 43: 853-861.
7. Walter, E. A., P. D. Greenberg, M. J. Gilbert, R. J. Finch, K. S. Watanabe, E. D. Thomas, and S. R. Riddell. 1995. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333: 1038-1044.
8. + T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants. Blood 108: 1406-1412.
9. + T-cells: the holy grail? Clin. Exp. Immunol. 138: 10-13.
10. +, cytomegalovirus- specific T cell subset after recovery of primary cytomegalovirus infection. J. Immunol. 173: 1834-1841.
11. +T lymphocytes with cellular maturation. J. Exp. Med. 203: 2865-2877.
12. + T cells during primary cytomegalovirus infection. J. Clin. Invest. 105: 541-548.
13. Levin, M. J., C. R. Rinaldo, Jr., P. L. Leary, J. A. Zaia, and M. S. Hirsch. 1979. Immune response to herpesvirus antigens in adults with acute cytomegaloviral mononucleosis. J. Infect. Dis. 140: 851-857.
14. Zanghellini, F., S. B. Boppana, V. C. Emery, P. D. Griffiths, and R. F. Pass. 1999. Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J. Infect. Dis. 180: 702-707.
15. Stern, H., G. Hannington, J. Booth, and D. Moncrieff. 1986. An early marker of fetal infection after primary cytomegalovirus infection in pregnancy. Br. Med. J. (Clin. Res. Ed.) 292: 718-720.
16. Fernando, S., J. M. Pearce, and J. C. Booth. 1993. Lymphocyte responses and virus excretion as risk factors for intrauterine infection with cytomegalovirus. J. Med. Virol. 41: 108-113.
17. Revello, M. G., D. Lilleri, M. Zavattoni, M. Furione, E. Genini, G. Comolli, and G. Gerna. 2006. Lymphoproliferative response in primary human cytomegalovirus (HCMV) infection is delayed in HCMV transmitter mothers. J. Infect. Dis. 193: 269-276.
18. Schrier, R. D., W. R. Freeman, C. A.Wiley, and J. A. McCutchan. 1995. Immune predispositions for cytomegalovirus retinitis in AIDS. J. Clin. Invest. 95: 1741-1746.
19. + T cell differentiation after primary infection. J. Infect. Dis. 198: 536-543.
20. Harari, A., F. Vallelian, P. R. Meylan, and G. Pantaleo. 2005. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J. Immunol. 174: 1037-1045.
21. + T cells are predominantly distributed among six phenotypically and functionally distinct subsets. J. Immunol. 175: 5765-5773.
22. + memory effector T cells reconstitutes antigen-induced IL-2 production. J. Exp. Med. 198: 947-955.
23. Serriari, N. E., F. Gondois-Rey, Y. Guillaume, E. B. Remmerswaal, S. Pastor, N. Messal, A. Truneh, I. Hirsch, R. A. van Lier, and D. Olive. 2010. B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function. J. Immunol. 185: 3140-3148.
24. Chipuk, J. E., T. Moldoveanu, F. Llambi, M. J. Parsons, and D. R. Green. 2010. The BCL-2 family reunion. Mol. Cell 37: 299-310.
25. Crispín, J. C., and G. C. Tsokos. 2009. Transcriptional regulation of IL-2 in health and autoimmunity. Autoimmun. Rev. 8: 190-195.
26. Frebel, H., K. Richter, and A. Oxenius. 2010. How chronic viral infections impact on antigen-specific T-cell responses. Eur. J. Immunol. 40: 654-663.
27. Revello, M. G., M. Zavattoni, A. Sarasini, E. Percivalle, L. Simoncini, and G. Gerna. 1998. Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognostic implications for pregnancy. J. Infect. Dis. 177: 1170-1175.
28. + T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J. Virol. 77: 10900-10909.
29. Musey, L. K., J. N. Krieger, J. P. Hughes, T. W. Schacker, L. Corey, and M. J. McElrath. 1999. Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection. J. Infect. Dis. 180: 278-284.
30. Folgori, A., E. Spada, M. Pezzanera, L. Ruggeri, A. Mele, A. R. Garbuglia, M. P. Perrone, P. Del Porto, E. Piccolella, R. Cortese, et al. 2006. Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance. Gut 55: 1012-1019.
31. Attarbaschi, T., M. Willheim, M. Ramharter, A. Hofmann, K. Wahl, H. Winkler, W. Graninger, and S.Winkler. 2003. T cell cytokine profile during primary Epstein-Barr virus infection (infectious mononucleosis). Eur. Cytokine Netw. 14: 34-39.
32. + T cells are a consequence of antigen load. J. Virol. 81: 2713-2725.
33. Semmo, N., G. Krashias, C. Willberg, and P. Klenerman. 2007. Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection. J. Viral Hepat. 14: 492-502.
34. + T cell responses in HIV-1 infected individuals initiating highly active antiretroviral therapy (HAART) is associated with renewed interleukin-2 production and responsiveness. Clin. Exp. Immunol. 134: 98-106.
35. + T cells and viremia: who's in control? Trends Immunol. 27: 119-124.
36. van de Berg, P. J., A. van Stijn, I. J. Ten Berge, and R. A. van Lier. 2008. A fingerprint left by cytomegalovirus infection in the human T cell compartment. J. Clin. Virol. 41: 213-217.
37. Koch, S., A. Larbi, D. Ozcelik, R. Solana, C. Gouttefangeas, S. Attig, A. Wikby, J. Strindhall, C. Franceschi, and G. Pawelec. 2007. Cytomegalovirus infection: a driving force in human T cell immunosenescence. Ann. N. Y. Acad. Sci. 1114: 23-35.
38. Gamadia, L. E., E. M. van Leeuwen, E. B. Remmerswaal, S. L. Yong, S. Surachno, P. M. Wertheim-van Dillen, I. J. Ten Berge, and R. A. Van Lier. 2004. The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines. J. Immunol. 172: 6107-6114.
39. Wherry, E. J., and R. Ahmed. 2004. Memory CD8 T-cell differentiation during viral infection. J. Virol. 78: 5535-5545.
40. + T cells is driven by viral replication and associated with T cell dysfunction. J. Immunol. 179: 1979-1987.
41. Brooks, D. G., L. Teyton, M. B. Oldstone, and D. B. McGavern. 2005. Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J. Virol. 79: 10514-10527.
42. Urbani, S., B. Amadei, D. Tola, G. Pedrazzi, L. Sacchelli, M. C. Cavallo, A. Orlandini, G. Missale, and C. Ferrari. 2008. Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. J. Hepatol. 48: 548-558.
43. Yi, J. S., M. A. Cox, and A. J. Zajac. 2010. T-cell exhaustion: characteristics, causes and conversion. Immunology 129: 474-481.
44. + T cell function by multiple costimulatory receptors during chronic HIV infection. J. Immunol. 185: 3007-3018.
45. Sester, U., D. Presser, J. Dirks, B. C. Gärtner, H. Köhler, and M. Sester. 2008. PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy. Am. J. Transplant. 8: 1486-1497.
46. + T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J. Exp. Med. 204: 2473-2485.
47. Pritts, T. A., Q. Wang, X. Sun, D. R. Fischer, E. S. Hungness, J. E. Fischer, H. R. Wong, and P. O. Hasselgren. 2002. The stress response decreases NF-κB activation in liver of endotoxemic mice. Shock 18: 33-37.
48. Shi, Y., Z. Tu, D. Tang, H. Zhang, M. Liu, K. Wang, S. K. Calderwood, and X. Xiao. 2006. The inhibition of LPS-induced production of inflammatory cytokines by HSP70 involves inactivation of the NF-κB pathway but not the MAPK pathways. Shock 26: 277-284.
49. + T cells respond to minimal amounts of Gag antigen due to high TCR avidity. PLoS Pathog. 6: e1000780.
50. + T-cell clones during primary human cytomegalovirus infection. Blood 108: 3121-3127.